Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function
出版年份 2018 全文链接
标题
Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function
作者
关键词
-
出版物
Frontiers in Aging Neuroscience
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-27
DOI
10.3389/fnagi.2018.00121
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease
- (2018) Jianhua Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
- (2017) Nan Chen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Taking out the garbage: cathepsin D and calcineurin in neurodegeneration
- (2017) Sabrina Büttner et al. Neural Regeneration Research
- Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
- (2017) Lena F. Burbulla et al. SCIENCE
- Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
- (2017) Fei Gao et al. Frontiers in Neurology
- The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits
- (2017) Jin Zhou et al. PLoS One
- The epigenetic regulation of HIF-1α by SIRT1 in MPP + treated SH-SY5Y cells
- (2016) Su-Yan Dong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Stabilization of HIF-1α by FG-4592 promotes functional recovery and neural protection in experimental spinal cord injury
- (2016) Kai Wu et al. BRAIN RESEARCH
- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
- (2016) R. Provenzano et al. Clinical Journal of the American Society of Nephrology
- Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons
- (2016) Johanna Mäkelä et al. NEUROPHARMACOLOGY
- Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity
- (2016) George Hoppe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis
- (2016) S Neitemeier et al. Cell Death & Disease
- Hypoxia Inducible Factors Modulate Mitochondrial Oxygen Consumption and Transcriptional Regulation of Nuclear-Encoded Electron Transport Chain Genes
- (2015) Hye Jin Hwang et al. BIOCHEMISTRY
- Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
- (2015) A. Besarab et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
- (2015) Anatole Besarab et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization
- (2014) Judith Eschbach et al. ANNALS OF NEUROLOGY
- Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease
- (2014) Ya Feng et al. NEUROSCIENCE LETTERS
- Altered Brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis–Ekbom Disease)
- (2014) Christopher J. Earley et al. SLEEP MEDICINE
- Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke
- (2013) Rachel E. Speer et al. FREE RADICAL BIOLOGY AND MEDICINE
- Computational Repositioning and Experimental Validation of Approved Drugs for HIF-Prolyl Hydroxylase Inhibition
- (2013) Mahesh Kumar Teli et al. Journal of Chemical Information and Modeling
- First-in-class anemia drug takes aim at Amgen's dominion
- (2013) Aaron Bouchie NATURE BIOTECHNOLOGY
- Autophagy and mitophagy in cellular damage control
- (2013) Jianhua Zhang Redox Biology
- Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
- (2011) Giuseppa Mudò et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mitochondria regulate autophagy by conserved signalling pathways
- (2011) Martin Graef et al. EMBO JOURNAL
- Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease
- (2011) Yuncheng Wu et al. NEUROSIGNALS
- Disease-associated amyloid and misfolded protein aggregates activate the inflammasome
- (2011) Seth L. Masters et al. TRENDS IN MOLECULAR MEDICINE
- The GTPase RAB20 is a HIF target with mitochondrial localization mediating apoptosis in hypoxia
- (2010) Thomas Hackenbeck et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
- (2010) Richard C. Scarpulla BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells
- (2010) Yuncheng Wu et al. NEUROCHEMISTRY INTERNATIONAL
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity
- (2009) Donna W. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMPK in Health and Disease
- (2009) Gregory R. Steinberg et al. PHYSIOLOGICAL REVIEWS
- Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
- (2008) Claire Henchcliffe et al. Nature clinical practice. Neurology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now